Patient Testimonial: Bryce, Cancer Signal Detected

After more than 25 years of military service, including time with the Force Reconnaissance Marines, Bryce knew that his chemical exposure at Camp Lejeune could carry potential health risks. Although he felt well and stayed current with his annual physicals, he decided to take the Galleri multi-cancer early detection test. In this patient testimonial, Bryce shares how the Galleri test detected a cancer signal and predicted a head and neck Cancer Signal Origin after his doctor ordered it. Follow-up imaging and diagnostic testing confirmed squamous cell carcinoma of the oropharynx. Bryce’s experience highlights why being proactive can be important, even when there are no symptoms and nothing unusual is found during a routine physical. His story is a powerful reminder to understand your personal risk factors, stay engaged in your health, and talk with your healthcare provider about whether Galleri may be right for you. Learn more about MCED testing: https://grail.com https://galleri.com Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Based on a clinical study of people ages 50 to 79 around 1% are expected to receive a Cancer Signal Detected result, which includes a predicted Cancer Signal Origin. After diagnostic evaluation, around 62% of these people are expected to have a confirmed cancer diagnosis. The overall sensitivity in study participants with head and neck cancer was 85.7% (63.2% for stage I, 82.4% stage II, 84.2% stage III, 96.0% stage IV). Rx only. See Important Safety Information: https://www.galleri.com/safety